8 Non-invasive methods for termination of second trimester pregnancy
Author:
- Marc BygdemanMBMarc Bygdeman
- 1 June 1990
- journal article
- review article
- Published by Elsevier in Bailliere's Clinical Obstetrics and Gynaecology
- Vol. 4 (2) , 351-359
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- 7 Anti-progesterones for the interruption of pregnancyBailliere's Clinical Obstetrics and Gynaecology, 1988
- Development of a vaginal gel containing 9-deoxo-16,16-dimethyl-9-methylene PGE2 for cervical dilatation and pregnancy terminationProstaglandins, Leukotrienes and Essential Fatty Acids, 1988
- Prostaglandin-induced pregnancy termination: Further studies using gemeprost (16, 16 dimethyl-trans-Δ2-PGE1 methyl ester vaginal pessaries in the early second trimesterProstaglandins, 1987
- Progesterone receptor blockageContraception, 1985
- The use of 16,16‐dimethyl‐transδ2 prostaglandin E1 methyl ester (gemeprost) vaginal pessaries for the termination of pregnancy in the early second trimester. A comparison with extra‐amniotic prostaglandin E2BJOG: An International Journal of Obstetrics & Gynaecology, 1984
- Termination of second-trimester pregnancy by laminaria and intramuscular injections of 15-methyl PGF2αor 16-phenoxy-ω-17, 18, 19, 20-tetranor PGE2methyl sulfonylamide: A randomized studyActa Obstetricia et Gynecologica Scandinavica, 1983
- Termination of second trimester pregnancy with laminaria and intramuscular 16 phenoxy-ω-17,18,19,20 tetranor PGE2 methylsuldonylamide (sulprostone) — A randomised studyProstaglandins, 1982
- The vaginal administration of 9-Deoxo-16,16-dimethyl-9-methylene PGE2 for second trimester abortionContraception, 1981
- Mid-trimester abortion by vaginal administration of 9-deoxo-16, 16-dimethyl-9-methylene-PGE2Contraception, 1980
- Termination of second trimester pregnancy with intramuscular administration of 16 phenoxy-ω-17,18,19,20 tetranor PGE2 methylsulfonylamideProstaglandins, 1978